With patent cliffs approaching for a number of blockbuster drugs and the America Invents Act coming into effect, life science patents are at the forefront of many executives’ minds. A smart patent strategy is necessary to protect costly R&D investment and ensure global sales success for up to 25 years in the future. Global patent strategy can make or break a company, decades after the paperwork has been filed. In this podast, Finnegan partner Michael J. Flibbert and attorney Marian T. Flattery discuss critical considerations life sciences leaders should think about when it comes to their patent strategy.

Click here to download podcast.